Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes

BACKGROUND: Inflammatory and hemostatic disorders in diabetic microangiopathy (DMA) can be linked to thrombin-activatable fibrinolysis inhibitor (TAFI) and its own gene polymorphisms. Thus, the study aimed to investigate the associations of plasma TAFI and gene polymorphisms with DMA in Chinese pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qinghua, Feng, Dujin, Pan, Lianlian, Wang, Huan, Wu, Yan, Zhong, Bin, Gong, Jianguang, Lin, Huijun, Fei, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655703/
https://www.ncbi.nlm.nih.gov/pubmed/38025709
http://dx.doi.org/10.7717/peerj.16352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655703/
https://www.ncbi.nlm.nih.gov/pubmed/38025709
http://dx.doi.org/10.7717/peerj.16352

Ejemplares similares